Zhejiang Hisun Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.050x

Zhejiang Hisun Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥438.43 Million ≈ $64.16 Million USD) by net assets (CN¥8.76 Billion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Zhejiang Hisun Pharmaceutical Co Ltd (1999–2025)

Cash flow conversion efficiency of Zhejiang Hisun Pharmaceutical Co Ltd from 1999 to 2025. This chart illustrates how Zhejiang Hisun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 600267 stock price and chart for real-time trading data and today's change.

Zhejiang Hisun Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Zhejiang Hisun Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Zhejiang Hisun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Hisun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Zhejiang Hisun Pharmaceutical Co Ltd stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Chicony Electronics Co Ltd TW:2385	0.018x
Shandong Humon Smelting Co Ltd SHE:002237	-0.109x
Webull Corp NASDAQ:BULL	0.038x
Insignia Financial Ltd AU:IFL	0.091x
Medicover AB (publ) ST:MCOV-B	0.170x
LEROY SEAFOOD GR.UNSP.ADR F:Z1L0	0.031x
Zhuzhou Hongda Electronics Corp Ltd Class A SHE:300726	-0.001x
Kaynes Technology India Limited NSE:KAYNES	-0.046x

Annual Cash Flow Conversion Efficiency for Zhejiang Hisun Pharmaceutical Co Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Hisun Pharmaceutical Co Ltd from 1999 to 2025. Review Zhejiang Hisun Pharmaceutical Co Ltd (600267) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥8.85 Billion ≈ $1.30 Billion	CN¥2.03 Billion ≈ $297.30 Million	0.230x	-6.88%
2024-12-31	CN¥8.58 Billion ≈ $1.26 Billion	CN¥2.11 Billion ≈ $309.42 Million	0.246x	+35.66%
2023-12-31	CN¥8.35 Billion ≈ $1.22 Billion	CN¥1.52 Billion ≈ $221.98 Million	0.182x	-26.73%
2022-12-31	CN¥8.33 Billion ≈ $1.22 Billion	CN¥2.07 Billion ≈ $302.28 Million	0.248x	+4.90%
2021-12-31	CN¥7.35 Billion ≈ $1.07 Billion	CN¥1.74 Billion ≈ $254.11 Million	0.236x	+22.79%
2020-12-31	CN¥8.26 Billion ≈ $1.21 Billion	CN¥1.59 Billion ≈ $232.61 Million	0.193x	+111.79%
2019-12-31	CN¥7.68 Billion ≈ $1.12 Billion	CN¥698.39 Million ≈ $102.20 Million	0.091x	-53.62%
2018-12-31	CN¥7.38 Billion ≈ $1.08 Billion	CN¥1.45 Billion ≈ $211.64 Million	0.196x	+24.42%
2017-12-31	CN¥7.88 Billion ≈ $1.15 Billion	CN¥1.24 Billion ≈ $181.55 Million	0.158x	+63.23%
2016-12-31	CN¥8.04 Billion ≈ $1.18 Billion	CN¥775.90 Million ≈ $113.54 Million	0.097x	+7.05%
2015-12-31	CN¥8.17 Billion ≈ $1.19 Billion	CN¥736.17 Million ≈ $107.72 Million	0.090x	+30.49%
2014-12-31	CN¥8.26 Billion ≈ $1.21 Billion	CN¥571.04 Million ≈ $83.56 Million	0.069x	-21.92%
2013-12-31	CN¥5.96 Billion ≈ $871.87 Million	CN¥527.25 Million ≈ $77.15 Million	0.088x	+22.41%
2012-12-31	CN¥5.20 Billion ≈ $760.59 Million	CN¥375.75 Million ≈ $54.98 Million	0.072x	-36.79%
2011-12-31	CN¥4.59 Billion ≈ $672.18 Million	CN¥525.31 Million ≈ $76.87 Million	0.114x	-38.37%
2010-12-31	CN¥2.74 Billion ≈ $401.57 Million	CN¥509.18 Million ≈ $74.51 Million	0.186x	-4.62%
2009-12-31	CN¥2.43 Billion ≈ $355.67 Million	CN¥472.85 Million ≈ $69.19 Million	0.195x	+36.20%
2008-12-31	CN¥1.55 Billion ≈ $226.70 Million	CN¥221.28 Million ≈ $32.38 Million	0.143x	-55.07%
2007-12-31	CN¥1.38 Billion ≈ $201.50 Million	CN¥437.72 Million ≈ $64.05 Million	0.318x	+273.86%
2006-12-31	CN¥1.27 Billion ≈ $185.92 Million	CN¥108.03 Million ≈ $15.81 Million	0.085x	-8.03%
2005-12-31	CN¥1.23 Billion ≈ $179.69 Million	CN¥113.53 Million ≈ $16.61 Million	0.092x	-64.49%
2004-12-31	CN¥1.20 Billion ≈ $175.90 Million	CN¥312.93 Million ≈ $45.79 Million	0.260x	-9.59%
2003-12-31	CN¥1.00 Billion ≈ $146.59 Million	CN¥288.45 Million ≈ $42.21 Million	0.288x	+96.58%
2002-12-31	CN¥824.83 Million ≈ $120.70 Million	CN¥120.82 Million ≈ $17.68 Million	0.146x	+66.14%
2001-12-31	CN¥784.18 Million ≈ $114.75 Million	CN¥69.14 Million ≈ $10.12 Million	0.088x	+19.97%
2000-12-31	CN¥757.90 Million ≈ $110.90 Million	CN¥55.70 Million ≈ $8.15 Million	0.073x	-43.75%
1999-12-31	CN¥249.88 Million ≈ $36.56 Million	CN¥32.64 Million ≈ $4.78 Million	0.131x	--

About Zhejiang Hisun Pharmaceutical Co Ltd

SHG:600267 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.27 Billion

CN¥15.52 Billion CNY

Market Cap Rank

#5522 Global

#930 in China

Share Price

CN¥12.95

Change (1 day)

+1.81%

52-Week Range

CN¥9.48 - CN¥14.37

All Time High

CN¥20.23